Quick Takeaways
- Paolo Pucci has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,090,732.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Paolo Pucci and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| WST | WEST PHARMACEUTICAL SERVICES INC | Director | $2,971,161 | 04 May 2026 | ||
| MRUS | Merus N.V. | Director | $119,571 | 12 Dec 2025 | ||
| REPL | Replimune Group, Inc. | Director | 01 Apr 2026 | |||
| TRIL | Trillium Therapeutics Inc. | Director | 17 Nov 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|